IDEAYA Biosciences, Inc. (IDYA) Financials
IDYA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 961.5 million | 26.2 million |
| 2023-12-31 | 649.3 million | 28.2 million |
| 2023-09-30 | 532.9 million | 24.9 million |
| 2023-06-30 | 527.6 million | 527.6 million |
IDYA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | -45.1 million | 6.3 million |
| 2023-12-31 | -24.6 million | 4.8 million |
| 2023-09-30 | -30.8 million | 5.3 million |
| 2023-06-30 | -34.3 million | 4.7 million |
IDYA Net Income
No data available :(
IDYA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | 698.8 million | - | 2.4 million |
| 2023-12-31 | 632.6 million | - | 2.9 million |
| 2023-09-30 | 511.1 million | - | 2.1 million |
| 2023-06-30 | 510.1 million | - | 2.6 million |
IDYA Shares Outstanding
IDYA Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | 1.3 million | 42.8 million | 8.2 million | - |
| 2023-12-31 | 838000 | 38.8 million | 7.1 million | 1000 |
| 2023-09-30 | 603000 | 33.7 million | 7.9 million | - |
| 2023-06-30 | 884000 | 29.2 million | 7.1 million | - |
IDYA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | - | 1.1 million |
| 2023-12-31 | 3.9 million | 1.0 million |
| 2023-09-30 | 8.0 million | 986000 |
| 2023-06-30 | 3.5 million | 998000 |
IDYA
Price: $40.50
52 week price:
Earnings Per Share: -2.00 USD
P/E Ratio: -23.10
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 546053
Market Capitalization: 3.1 billion